Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients

Hurşitoğlu, Onur; Belge Kurutaş, Ergül; Strawbridge, Rebecca; Oner, Erkan; Güngör, Meltem; Tuman, Taha Can; Uygur, Ömer Faruk

doi:10.1016/j.pnpbp.2022.110670

Makale Tam Makale Uluslararası 2022 Açık erişimli

Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients

Onur Hurşitoğlu, Ergül Belge Kurutaş, Rebecca Strawbridge, Erkan Oner, Meltem Güngör, Taha Can Tuman, Ömer Faruk Uygur

Progress in Neuro-Psychopharmacology and Biological Psychiatry Cilt 8 · ss. 121–129 · 01.11.2022

DOI ile aç

Atıf için künye

Hurşitoğlu, O., Belge Kurutaş, E., Strawbridge, R., Oner, E., Güngör, M., Tuman, T. C., & Uygur, Ö. F. (2022). Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 8, 121–129. https://doi.org/10.1016/j.pnpbp.2022.110670

BibTeX

@article{hursitoglu2022-246069,
  author = {Hurşitoğlu, Onur and Belge Kurutaş, Ergül and Strawbridge, Rebecca and Oner, Erkan and Güngör, Meltem and Tuman, Taha Can and Uygur, Ömer Faruk},
  title = {Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients},
  journal = {Progress in Neuro-Psychopharmacology and Biological Psychiatry},
  year = {2022},
  volume = {8},
  pages = {121--129},
  issn = {0278-5846},
  doi = {10.1016/j.pnpbp.2022.110670},
  url = {https://akademik.atauni.edu.tr/yayinlar/246069-serum-nox1-and-raftlin-as-new-potential-biomarkers-of-major-depressive-disorder}
}